Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
Corvus Pharmaceuticals, Inc. (CRVS) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding of 6.35 million shares as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions · last filed 2022-03-10
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 6.35M shares.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 6.66M shares.
- 2019-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 5.64M shares.
- 2018-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 3.78M shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding |
|---|---|
| 2021-12-31 | 6.35M shares 10-K · filed 2022-03-10 |
| 2020-12-31 | 6.66M shares 10-K · filed 2022-03-10 |
| 2019-12-31 | 5.64M shares 10-K · filed 2021-03-25 |
| 2018-12-31 | 3.78M shares 10-K · filed 2020-03-09 |
| 2017-12-31 | 3.01M shares 10-K · filed 2019-03-07 |
| 2016-12-31 | 2.35M shares 10-K · filed 2018-03-01 |
| 2015-12-31 | 784.14K shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |